The Global Artesunate API Market was valued at USD 125.4 Million in 2024 and is projected to reach USD 245.9 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 7.8% during the forecast period (2024–2032). This significant growth is being driven by the persistent global burden of malaria, rising government initiatives for malaria eradication, and the accelerating adoption of Artemisinin-based Combination Therapies (ACTs) as the first-line treatment across endemic regions.

As the pharmaceutical industry intensifies its focus on combating infectious diseases in developing nations, the spotlight is on the key Active Pharmaceutical Ingredient (API) manufacturers who are driving production, ensuring quality, and securing the supply chain for this life-saving antimalarial compound. In this blog, we profile the Top 10 Companies in the Artesunate API Industry—a mix of established pharmaceutical giants and specialized API producers shaping the future of global malaria treatment.

---

🔟 1. Hunan Huateng Pharmaceutical Co., Ltd.

Headquarters: Changsha, Hunan, China
Key Offering: High-Purity Artesunate API (0.98, 0.99), Artemisinin Derivatives

Hunan Huateng Pharmaceutical is a leading global supplier of artesunate API, renowned for its vertically integrated production process from artemisinin extraction to finished API. The company holds WHO prequalification for its artesunate, making it a critical supplier to international procurement agencies like The Global Fund. Their state-of-the-art facilities comply with stringent cGMP standards, ensuring batch-to-batch consistency for pharmaceutical formulations.

Quality and Expansion Initiatives:

• WHO-prequalified manufacturing facility supplying over 30% of global volume

• Continuous investment in semi-synthetic artemisinin technology to reduce agricultural dependency

• Strategic long-term contracts with national malaria control programs in Africa

Download FREE Sample Report: Artesunate API Market – View in Detailed Research Report

---

9️⃣ 2. Ipca Laboratories Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Artesunate API, Artesunate Tablets, Artesunate Injection

Ipca Laboratories is a major force in the antimalarial API space, with a robust portfolio that includes artesunate for both domestic use and export. The company’s vertically integrated operations encompass the entire value chain, contributing to cost efficiency and supply chain security. Ipca’s artesunate API is utilized in its own formulations, which are widely distributed in high-burden malaria regions across Africa and Asia.

Quality and Expansion Initiatives:

• Multiple WHO-prequalified finished product formulations containing artesunate API

• Significant capacity expansion projects to meet rising global demand

• Focus on backward integration to secure artemisinin supply

---

8️⃣ 3. Cipla Limited

Headquarters: Mumbai, Maharashtra, India
Key Offering: Artesunate API, Fixed-Dose Combinations (ACTs), Injectable Artesunate

Cipla is a globally recognized pharmaceutical company with a strong commitment to affordable healthcare, including antimalarial treatments. The company manufactures artesunate API for its wide range of ACTs, which are essential for both uncomplicated and severe malaria. Cipla’s extensive distribution network in Africa ensures that quality-assured artesunate-based medicines reach patients in need.

Quality and Expansion Initiatives:

• Development of artesunate-based fixed-dose combinations for improved patient compliance

• Investment in R&D for novel artesunate formulations and delivery systems

• Partnerships with global health organizations for accessible malaria treatment

---

7️⃣ 4. Kunming Baker Norton Pharmaceutical Co., Ltd.

Headquarters: Kunming, Yunnan, China
Key Offering: Artesunate API, Artemisinin, Dihydroartemisinin

Located in Yunnan province, a key region for Artemisia annua cultivation, Kunming Baker Norton leverages its geographic advantage to produce high-quality artesunate API. The company is a significant exporter, with a strong focus on meeting international pharmacopoeial standards. Their expertise in the purification process ensures high-yield production of artesunate suitable for injectable and oral formulations.

Quality and Expansion Initiatives:

• Proximity to raw material source ensuring stable artemisinin supply

• Advanced purification technologies for high-purity artesunate output

• Expansion of cGMP-compliant production lines to scale up capacity

---

6️⃣ 5. Sanofi

Headquarters: Paris, France
Key Offering: Artesunate Amodiaquine Winthrop®, Artesunate API for injection

Sanofi, a global pharmaceutical leader, plays a pivotal role in the artesunate market through its not-for-profit initiative, which supplies high-quality ACTs to endemic countries. While not a primary API manufacturer for the open market, Sanofi’s commitment to artesunate production for global health impacts market dynamics by setting high-quality benchmarks and ensuring a stable supply for public health programs.

Quality and Expansion Initiatives:

• Dedicated production facility in Italy for artesunate-based ACTs supplied to the public sector

• Not-for-profit pricing model for malaria-endemic countries

• Strong partnerships with the WHO and AMFm (Affordable Medicines Facility-malaria)

Download FREE Sample Report: Artesunate API Market – View in Detailed Research Report

---

5️⃣ 6. Gonane Pharma

Headquarters: Hyderabad, Telangana, India
Key Offering: High-Purity Artesunate API, Custom Synthesis

Gonane Pharma is a specialized API manufacturer focusing on niche molecules, including artesunate. The company has carved out a reputation for producing high-purity artesunate API that meets the demanding specifications of regulated markets. Their flexible manufacturing capabilities allow them to serve both large pharmaceutical companies and smaller generic drug makers.

Quality and Expansion Initiatives:

• Focus on high-margin, high-purity artesunate segments

• Agile manufacturing approach catering to diverse client requirements

• Investment in analytical method development for impurity profiling

---

4️⃣ 7. Mangalam Drugs & Organics Ltd.

Headquarters: Mumbai, Maharashtra, India
Key Offering: Artesunate API, Artemisinin Derivatives, Intermediates

Mangalam Drugs & Organics has a long-standing presence in the API manufacturing sector, with artesunate being a key product in its portfolio. The company supplies artesunate API to formulation manufacturers in India and abroad, contributing to the availability of affordable antimalarial drugs. Their strength lies in efficient chemical synthesis and process optimization.

Quality and Expansion Initiatives:

• Established track record in API manufacturing with a focus on cost competitiveness

• Ongoing process optimization to improve yields and reduce production costs

• Strategic focus on emerging markets with high malaria burden

---

3️⃣ 8. Nanjing Hicin Pharmaceutical Co., Ltd.

Headquarters: Nanjing, Jiangsu, China
Key Offering: Artesunate API, Pharmaceutical Intermediates

Nanjing Hicin Pharmaceutical is a Chinese API manufacturer with expertise in artemisinin-derived compounds. The company produces artesunate API that meets the requirements of various international markets. Their strategic location in an industrial hub provides advantages in logistics and access to chemical inputs.

Quality and Expansion Initiatives:

• Strong R&D focus on improving artesunate synthesis pathways

• Competitive pricing strategy for cost-sensitive markets

• Expansion of regulatory filings in key importing countries

---

2️⃣ 9. Micro Orgo Chem

Headquarters: Hyderabad, Telangana, India
Key Offering: Artesunate API, Custom Synthesis Services

Micro Orgo Chem is an emerging player in the artesunate API market, specializing in the production of high-quality active ingredients. The company has invested in modern manufacturing infrastructure to produce artesunate that complies with international quality standards. Their customer-centric approach allows them to build strong relationships with formulation partners.

Quality and Expansion Initiatives:

• Investment in modern manufacturing and quality control infrastructure

• Focus on building a reputation for reliability and consistent quality

• Strategic plans for capacity expansion to capture growing market share

---

1️⃣ 10. Solara Active Pharma Sciences Ltd.

Headquarters: Chennai, Tamil Nadu, India
Key Offering: Artesunate API, Focused API Portfolio

Solara Active Pharma Sciences is a dedicated API company with a focused portfolio that includes artesunate. The company’s vertically integrated operations and scale provide competitive advantages in the market. Solara’s emphasis on regulatory compliance and quality systems positions it as a reliable supplier for regulated markets.

Quality and Expansion Initiatives:

• Vertically integrated manufacturing capabilities for cost control

• Strong regulatory track record with filings in multiple countries

• Strategic focus on building a robust and scalable artesunate API business

Get Full Report Here: Artesunate API Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Artesunate API is Driven by Innovation and Access

The artesunate API market is undergoing a significant transformation. While demand from traditional malaria treatment remains strong, the industry is investing in process innovations, capacity expansions, and exploring new therapeutic applications to ensure sustainable growth and broader patient access.

📈 Key Trends Shaping the Market:

• Rapid capacity expansion by Chinese and Indian API manufacturers to meet WHO demand

• Regulatory push for quality assurance and WHO prequalification of API sources

• Technological advancements in semi-synthetic artemisinin production to stabilize supply

• Growing research into non-malarial applications of artesunate, particularly in oncology

Get Full Report Here: Artesunate API Market – View in Detailed Research Report

The companies listed above are not only supplying a critical antimalarial ingredient—they’re spearheading the global fight against malaria through quality, innovation, and commitment to accessibility.